Business Description
Cellromax Science Co Ltd
ISIN : KR7471820001
Compare
Compare
Traded in other countries / regions
471820.Korea IPO Date
2024-12-13Description
Cellromax Science Co Ltd is engaged in product development and distribution in the health-functional food market using pharmacies and online B2C e-commerce platforms and also develops various products in the general pharmaceutical and cosmetics sectors every year. Its products include Health functional food, Cosmetics, and General medicine.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.06 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.24 | |||||
| Interest Coverage | 207.89 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.52 | |||||
| 9-Day RSI | 46.33 | |||||
| 14-Day RSI | 39.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.42 | |||||
| Quick Ratio | 4.13 | |||||
| Cash Ratio | 3.75 | |||||
| Days Inventory | 559.43 | |||||
| Days Sales Outstanding | 32.86 | |||||
| Days Payable | 148.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.1 | |||||
| Operating Margin % | 26.98 | |||||
| Net Margin % | 25.44 | |||||
| FCF Margin % | 80.06 | |||||
| ROE % | 4.13 | |||||
| ROA % | 3.73 | |||||
| ROIC % | 4.89 | |||||
| ROC (Joel Greenblatt) % | 22.84 | |||||
| ROCE % | 5.19 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.78 | |||||
| PE Ratio without NRI | 42.55 | |||||
| PS Ratio | 10.62 | |||||
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 2.05 | |||||
| Price-to-Free-Cash-Flow | 13.25 | |||||
| Price-to-Operating-Cash-Flow | 11.46 | |||||
| EV-to-EBIT | 29.76 | |||||
| EV-to-EBITDA | 28.05 | |||||
| EV-to-Revenue | 9.7 | |||||
| EV-to-FCF | 11.82 | |||||
| Price-to-Graham-Number | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 5.13 | |||||
| Price-to-Net-Cash | 8.49 | |||||
| Earnings Yield (Greenblatt) % | 3.36 | |||||
| FCF Yield % | 6.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellromax Science Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 5,475.089 | ||
| EPS (TTM) (â‚©) | 135 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 39.33 | ||
| 14-Day ATR (â‚©) | 524.610161 | ||
| 20-Day SMA (â‚©) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (â‚©) | 4815 - 8700 | ||
| Shares Outstanding (Mil) | 11.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellromax Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellromax Science Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cellromax Science Co Ltd Frequently Asked Questions
What is Cellromax Science Co Ltd(XKRX:471820)'s stock price today?
The current price of XKRX:471820 is â‚©5640.00. The 52 week high of XKRX:471820 is â‚©8700.00 and 52 week low is â‚©4815.00.
When is next earnings date of Cellromax Science Co Ltd(XKRX:471820)?
The next earnings date of Cellromax Science Co Ltd(XKRX:471820) is .
Does Cellromax Science Co Ltd(XKRX:471820) pay dividends? If so, how much?
Cellromax Science Co Ltd(XKRX:471820) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers